Pfizer secures tariff exemption in deal to lower US drug prices
PositiveFinancial Markets
Pfizer has successfully negotiated a tariff exemption that will help lower drug prices in the U.S. This deal is significant as it aims to make essential medications more affordable for Americans, addressing a critical issue in healthcare accessibility. By reducing costs, Pfizer is not only enhancing its market position but also contributing to public health, which is a win for both the company and consumers.
— Curated by the World Pulse Now AI Editorial System